Summary
This business specializes in AI-driven computational analysis to study the human immune system, aiming to unlock insights that enhance research and develop better therapies. It focuses on single-cell data analysis to provide detailed insights into immune responses, particularly in the context of targeted treatments and drug development in immuno-oncology. The company collaborates with pharmaceutical and academic organizations to maximize the value of biological data.
Link
Link